Načítá se...
Fenfluramine: New Treatment for Seizures in Dravet Syndrome
Investigators for the FAiRE DS Study Group assessed the efficacy and safety of Fenfluramine for treating seizures in patients less than 18 y.o. with Dravet Syndrome in an international double-blind, placebo-controlled clinical trial. A total of 119 patients (mean age 9.0 y, 54% male) were enrolled i...
Uloženo v:
| Vydáno v: | Pediatr Neurol Briefs |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Pediatric Neurology Briefs Publishers
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7071945/ https://ncbi.nlm.nih.gov/pubmed/32189958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15844/pedneurbriefs-34-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|